Testing effectiveness (Phase 2)Active Not RecruitingNCT06874621
What this trial is testing
VY7523-102: Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study in Participants With Early Alzheimer's Disease
Who this might be right for
Alzheimer's Disease (AD)
Voyager Therapeutics 52